Flagship merger ‘effectively scrapped’ after ‘wasting millions’
The leader of a flagship ‘hub and spoke’ pathology merger has criticised regulators after the project was effectively dropped due to delays in receiving £31m of capital that was allocated to the scheme in 2018.
You need to be a subscriber to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All HSJ news by sector, topic & region
- Breaking News announcements
- App for mobile and offline reading
- Comment and Daily Insights newsletters
- Regional roundup newsletters
- Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
- 10 expert briefings every fortnight (Premium only)
Already a subscriber? Sign into your account here